
BioCatch
BioCatch is a company based in Israel. Builders in Fintech has recorded 3 equity rounds for BioCatch, most recently a series c round of $20M on 1 October 2020.
Added ·
- $195M
- Series C · $20M · 1 October 2020
Timeline
Series C · $20M · American Express Ventures, CreditEase, Industry Ventures, Maverick Ventures, Opportunities, OurCrowd
Series C · $145M · Opportunities (lead)
Growth · $30M · Maverick Ventures (lead), American Express Ventures, CreditEase, JANVEST Capital, Kreos Capital, NexStar Partners, OurCrowd
All funding rounds in the database
Product
Behavioural biometrics to stop fraud and scams
Fraud and risk
BioCatch uses behavioural biometrics to detect fraud and financial crime in digital banking. Its BioCatch Connect platform analyses how users interact with their devices in real time to catch account-opening fraud, account takeover, social engineering scams and mule accounts, with tools for device intelligence and strong customer authentication.
Agent-Ready 1/5
- Discoverable — Can an agent find and read it?Not found on 3 November 2026
- Documented — Can it understand the API without a login?Not found on 3 November 2026
- Testable — Can it try the API without a sales call?Not found on 3 November 2026
- Connectable — Can it connect directly (MCP)?Not found on 3 November 2026
- Trusted — Can it see who runs it securely?Found
Description from the company website · Source
In the news
- New Zealand banks join forces with BioCatch on new scam-detection system (opens in a new tab)
- BioCatch launches agentic AI detection tech (opens in a new tab)
- BioCatch launches public-private advisory board to help governments combat fraud (opens in a new tab)
Headlines from third-party publications, matched automatically. Links go to the original source.